LIGAND PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC NOTE 0.750% 8/1, CUSIP 53220kad0.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC NOTE 0.750% 8/1, CUSIP 53220kad0.